• Atropine Sulfate injection, American Regent
  0.4 mg/mL, 1 mL single dose vial, 25 count (NDC 00517-0401-25)

• • American Regent did not provide a reason for the shortage of atropine injection.
  • Pfizer states the shortage was due to manufacturing delays.

• Atropine Sulfate injection, Amphastar
  0.1 mg/mL, 10 mL Luer-Jet syringe, 10 count (NDC 76329-3339-01)

Estimated Resupply Dates

• • American Regent has atropine 0.4 mg/mL 1 mL ampules and 1 mg/mL 1 mL vials available in limited supply.
  • Pfizer has atropine 0.05 mg/mL 5 mL Ansyr syringes on allocation. The 0.1 mg/mL 10 mL LifeShield syringes are on back order and the company estimates a release date of late-September 2017. The 0.1 mg/mL 5 mL LifeShield syringes are on back order and the company estimates a release date of late-August 2017. The 0.1 mg/mL 10 mL Ansyr syringes are on back order and the company estimates a release date of mid-July 2017.

Safety

• FDA has extended the expiration dating for certain lots of atropine 0.1 mg/mL 5 mL and 10 mL Abboject syringes.